Breakthrough Therapy Designation for New Drugs-Reply

JAMA. 2018 Nov 20;320(19):2042-2043. doi: 10.1001/jama.2018.15942.

Authors

Jeremy Puthumana¹, Joshua D Wallach¹, Joseph S Ross¹

Affiliation

¹ Yale University School of Medicine, New Haven, Connecticut.

PMID: 30458490
DOI: 10.1001/jama.2018.15942

No abstract available

Publication types

Letter
Comment

MeSH terms

Drug Approval*
United States Food and Drug Administration*